Antimicrobial resistance of Mycoplasma infection in outpatients of gynecology
Wan Xiong-pin
Abstract
Wan Xiong-pin
Abstract
ObjectiveTo investigate the antimicrobial resistance of Ureaplasma urealyticum(Uu) and Mycoplasma homonis(Mh) isolated from outpatients in our hospital from 2003 to 2004.MethodsThe test kit Mycoplasma IST 2 of BioMerieux was used for identification,and susceptibility testing of Uu and Mh isolates.ResultsUu,Mh and Uu+Mh co-infection were identified from 44.8%(284/634),0.6%(4/634) and 9.5%(60/634) of 634 clinical specimens,respectively.The Uu isolates were least resistant to josamycin(0.4%),but highly resistant to ofloxacin(31.7%) and ciprofloxacin(61.3%).The prevalence of Mycoplasma infection was similar between year 2003 and 2004.It was 57.4%(112/195) and 53.8%(236/439) respectively.Uu+Mh co-infection slightly increased from 10.7%(12/112) in 2003 to 20.3%(48/236) in 2004.ConclusionsUu is one of the key pathogens causing infections in women.The resistance of Mycoplasma is serious.Antimicrobial therapy should be rationally used in order to delay the emergence of resistant strain.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ObjectiveTo investigate the antimicrobial resistance of Ureaplasma urealyticum(Uu) and Mycoplasma homonis(Mh) isolated from outpatients in our hospital from 2003 to 2004.MethodsThe test kit Mycoplasma IST 2 of BioMerieux was used for identification,and susceptibility testing of Uu and Mh isolates.ResultsUu,Mh and Uu+Mh co-infection were identified from 44.8%(284/634),0.6%(4/634) and 9.5%(60/634) of 634 clinical specimens,respectively.The Uu isolates were least resistant to josamycin(0.4%),but highly resistant to ofloxacin(31.7%) and ciprofloxacin(61.3%).The prevalence of Mycoplasma infection was similar between year 2003 and 2004.It was 57.4%(112/195) and 53.8%(236/439) respectively.Uu+Mh co-infection slightly increased from 10.7%(12/112) in 2003 to 20.3%(48/236) in 2004.ConclusionsUu is one of the key pathogens causing infections in women.The resistance of Mycoplasma is serious.Antimicrobial therapy should be rationally used in order to delay the emergence of resistant strain.
Key concepts: Josamycin, Ureaplasma urealyticum, Mycoplasma, Ofloxacin, Microbiology, Ciprofloxacin, Antimicrobial, Medicine